Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
STEMVAC Vaccine for Lung Cancer
Recruiting1 awardPhase 2
Seattle, Washington
This trial tests a new DNA-based vaccine called STEMVAC, combined with GM-CSF, in patients with advanced lung cancer. The vaccine helps the immune system recognize and attack cancer cells, while GM-CSF boosts this response. The goal is to see if this combination can shrink tumors in these patients. GM-CSF has been used in various tumor vaccines to stimulate the immune system and enhance antitumor responses.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service